Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness

Obstet Gynecol. 2023 Aug 1;142(2):234-235. doi: 10.1097/AOG.0000000000005253. Epub 2023 May 24.

Author

Valerie French¹

Affiliation

¹ Valerie French is from the University of Kansas Department of Obstetrics and Gynecology, Kansas City, Kansas; vfrench@kumc.edu.

PMID: 37225395
DOI: 10.1097/AOG.0000000000005253

No abstract available

MeSH terms

Abortifacient Agents, Steroidal* / therapeutic use
Abortion, Induced*
Female
Humans
Mifepristone / therapeutic use
Pregnancy
United States
United States Food and Drug Administration

Substances

Mifepristone
Abortifacient Agents, Steroidal